A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 10 Oct 2017
At a glance
- Drugs Drospirenone (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Leon Farma
- 04 Oct 2017 Planned End Date changed from 1 Oct 2017 to 15 Oct 2017.
- 18 Nov 2016 Planned End Date changed from 1 Jul 2017 to 1 Oct 2017.
- 18 Nov 2016 Status changed from completed to active, no longer recruiting.